68 related articles for article (PubMed ID: 15488614)
1. Multiplex detection and quantitation of latent and lytic transcripts of human herpesvirus-8 using RNase Protection Assay.
Cloutier N; Gravel A; Flamand L
J Virol Methods; 2004 Dec; 122(1):1-7. PubMed ID: 15488614
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
3. Latent and lytic HHV-8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients.
Polstra AM; Goudsmit J; Cornelissen M
J Med Virol; 2003 Aug; 70(4):624-7. PubMed ID: 12794727
[TBL] [Abstract][Full Text] [Related]
4. Dominant human herpesvirus type 8 RNA transcripts in classical and AIDS-related Kaposi's sarcoma.
Linderoth J; Rambech E; Dictor M
J Pathol; 1999 Apr; 187(5):582-7. PubMed ID: 10398125
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody.
Chan SR; Bloomer C; Chandran B
Virology; 1998 Jan; 240(1):118-26. PubMed ID: 9448696
[TBL] [Abstract][Full Text] [Related]
6. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
7. Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.
Brown HJ; McBride WH; Zack JA; Sun R
Antivir Ther; 2005; 10(6):745-51. PubMed ID: 16218174
[TBL] [Abstract][Full Text] [Related]
8. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
9. Optimization of chemical induction conditions for human herpesvirus 8 (HHV-8) reactivation with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) from latently-infected BC-3 cells.
Ma W; Galvin TA; Ma H; Ma Y; Muller J; Khan AS
Biologicals; 2011 May; 39(3):158-66. PubMed ID: 21470875
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay.
Chohan BH; Taylor H; Obrigewitch R; Lavreys L; Richardson BA; Mandaliya KN; Bwayo JJ; Kreiss JK; Morrow RA
J Clin Virol; 2004 Jun; 30(2):137-44. PubMed ID: 15125869
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) ORF54 encodes a functional dUTPase expressed in the lytic replication cycle.
Kremmer E; Sommer P; Holzer D; Galetsky SA; Molochkov VA; Gurtsevitch V; Winkelmann C; Lisner R; Niedobitek G; Gr Sser FA
J Gen Virol; 1999 May; 80 ( Pt 5)():1305-1310. PubMed ID: 10355777
[TBL] [Abstract][Full Text] [Related]
12. Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4.
Qin D; Zeng Y; Qian C; Huang Z; Lv Z; Cheng L; Yao S; Tang Q; Chen X; Lu C
Cell Microbiol; 2008 Mar; 10(3):713-28. PubMed ID: 18042256
[TBL] [Abstract][Full Text] [Related]
13. Differential HHV-6A gene expression in T cells and primary human astrocytes based on multi-virus array analysis.
Yao K; Mandel M; Akyani N; Maynard K; Sengamalay N; Fotheringham J; Ghedin E; Kashanchi F; Jacobson S
Glia; 2006 Jun; 53(8):789-98. PubMed ID: 16541415
[TBL] [Abstract][Full Text] [Related]
14. Transcripts of the human herpesvirus 8 genome in skin lesions and peripheral blood mononuclear cells of a patient with classic Kaposi's sarcoma.
Yoshii N; Kanekura T; Eizuru Y; Setoyama M; Kanzaki T; Yamanishi K
Clin Exp Dermatol; 2006 Jan; 31(1):125-7. PubMed ID: 16309502
[TBL] [Abstract][Full Text] [Related]
15. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
Schulz TF
J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
[TBL] [Abstract][Full Text] [Related]
16. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.
Krug LT; Pozharskaya VP; Yu Y; Inoue N; Offermann MK
J Virol; 2004 Aug; 78(15):8359-71. PubMed ID: 15254208
[TBL] [Abstract][Full Text] [Related]
18. Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression.
Bergallo M; Costa C; Baro S; Musso T; Balbo L; Merlino C; Cavallo R
J Biotechnol; 2007 Feb; 128(3):462-76. PubMed ID: 17147963
[TBL] [Abstract][Full Text] [Related]
19. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
20. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
Cho HJ; Yu F; Sun R; Lee D; Song MJ
Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]